Monday, June 15, 2026

“Barking at the Wind”: Pyongyang Snubs Seoul’s Regret with a Rain of Missiles

North Korea's missile provocations follow President Lee's regret over a drone incident, signaling continued hostility towards South Korea.

North Korea’s 9th Party Congress: Key Delegate Selections and What It Means for February 2026

North Korea's Central Committee meeting prepares for the upcoming 9th Party Congress, electing new leadership and representatives.

SPACEX VS. PYONGYANG: Why South Korea’s Private Rocket Race Is Really A Desperate Military Push

South Korea's space sector shifts to private launches, with Innospace's Hanbit Nano and Hanwha's Nuri rocket set for significant missions.

Tag: pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

DongKoo Bio & Pharma Unveils TERABIOTICS PRO 1.06 to Strengthen Health Supplement Business

Donggu Bio Pharmaceutical announces the launch of its new 5th generation probiotic product, TERABIOTICS PRO 1.06.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Dong-A University Hospital Launches AI-Driven thynC Monitoring System

Dong-A University Hospital launches AI-powered smart bed system thynC, enhancing patient monitoring and safety across general wards.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

Stoboclo: How This New Osteoporosis Treatment Achieved 11.8 Billion KRW in Sales in Just One Year

Daewoong Pharmaceutical's Stoboclo, a biosimilar for osteoporosis, achieved 11.8 billion KRW in sales in its first year, marking rapid growth.

Revolutionizing Patient Care: How thynC AI Monitoring Transforms Hospital Safety in Seoul

Seoul Sungsim Hospital adopts AI bed monitoring system thynC to enhance patient safety and streamline nursing care management.

April 2026: Major Regulatory Actions on Herbal Patches and Antibiotics in South Korea

The FDA suspended manufacturing and sales of several products for regulatory violations, including herbal patches and antibiotic tablets.

A Future Of 24/7 Health Monitoring: Korea Pushes AI-Driven Care Forward

Daewoong Pharmaceutical showcases its digital healthcare innovations, achieving significant market share with AI solutions for patient care.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.